Skip to content


Call for papers: Emerging biomarkers in oncology research and practice

Emerging biomarkers in oncology research and practiceWe are pleased to announce Cancer Cell International is now accepting submissions for a thematic series on 'Emerging biomarkers in oncology research and practice'. 

Guest edited by Dr Aejaz Nasir, the series aims to cover cutting-edge developments in the field of oncology and pathology with reference to diagnostic, prognostic, predictive and pharmacodynamics biomarkers. 

Read more


Most accessed articles RSS

View all articles

Aims and scope

Cancer Cell International publishes articles on all aspects of cancer cell biology, originating largely from, but not limited to, work using cell culture techniques.

Read more


Y Eugene Chin, Shanghai Institute of Biological Sciences, China
Domenico Coppola, Moffitt Cancer Center, USA

Associate Editor spotlight

Matteo FassanMariano Bizzarri

Dr Mariano Bizzarri is Associate Professor of Clinical Pathology in the Department of Experimental Medicine at University Sapienza, Rome, and Head of the Interdepartmental Systems Biology Center (SBGLab). He is a cancer researcher with expertise in the study of Systems Biology approach in the integrative understanding of cell and tumor biology, namely by focusing on cell phenotypic transition, tumor reversion and cell-microenvironment cross-talk.

Editorial Board spotlight

Sritama NathGo J. Yoshida

Dr. Go J. Yoshida graduated from Keio University School of Medicine in 2010 and obtained his PhD in 2013 with research on redox stress regulation in gastric and breast cancer stem cells through CD44 variant-xCT interaction. Since 2014, he has been working mainly on the pathophysiological significance of autophagy at the Medical Research Institute, Tokyo Medical and Dental University. He has recently reported the therapeutic potential of autophagic cell death in glioblastoma stem cells.


2017 Journal Metrics